SCHEMBL3293154

SCHEMBL3293154

COc1cc(OC)c(C(=O)N[C@@H]2C[C@H]2c2ccccc2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.52
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
TLR2 O60603 2/20 0.51
TLR1 Q15399 2/20 0.51
ROCK2 O75116 1/20 0.51
ROCK1 Q13464 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SPTLC2 O15270 5/20 0.48
DRD2 P14416 4/20 0.48
DRD4 P21917 4/20 0.48
DRD3 P35462 4/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
NR1I2 O75469 1/20 0.48
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48
HTR1A P08908 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3293152 1.00 KDM1A (0.52) KDM1AMAOAMAOBTLR2TLR1
SCHEMBL3288137 0.86 ROCK2 (0.53) KDM1AMAOAMAOBTLR2TLR1
SCHEMBL3288136 0.86 ROCK2 (0.53) KDM1AMAOAMAOBTLR2TLR1
SCHEMBL3296623 0.85 CA1 (0.48) KDM1AALDH1A1KMT2AHTR3ACYP2D6
SCHEMBL3296626 0.85 CA1 (0.48) KDM1AALDH1A1KMT2AHTR3ACYP2D6
SCHEMBL3288027 0.83 ROCK2 (0.61) KDM1AMAOAMAOBTLR2TLR1
SCHEMBL3295195 0.78 KDM4E (0.47) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL3295193 0.78 KDM4E (0.47) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL3295200 0.78 KDM4E (0.47) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL6565673 0.77 CNR1 (0.65) KDM1AMAOAMAOBSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2207540-B1 CYCLOPROPYL ARYL AMIDE DERIVATIVES AND USES THEREOF HOFFMANN LA ROCHE (CH) 2014-02-26 EP disclosed
US-7723391-B2 Cyclopropyl aryl amide derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2010-05-25 US disclosed
US-7723391-B2 Cyclopropyl aryl amide derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2010-05-25 US disclosed
US-20090093525-A1 Cyclopropyl aryl amide derivatives and uses thereof ROCHE PALO ALTO LLC 2009-04-09 US disclosed
US-20090093525-A1 Cyclopropyl aryl amide derivatives and uses thereof ROCHE PALO ALTO LLC 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093525-A1 Cyclopropyl aryl amide derivatives and uses thereof AR, ADRA2A, ADRA1A KDM1A 1930/4885MAOA 899/4885MAOB 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.